Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
ACE	O
Inhibitors	O
/	O
Augmentin	O
Attending:	O
___	O
Chief	O
Complaint:	O
___	O
is	O
a	O
___	O
woman	O
with	O
a	O
history	O
of	O
HTN,	O
HLD,	O
a-fib	O
s/p	O
ablation,	O
___'s	O
thyroiditis,	O
and	O
recent	O
diagnosis	O
of	O
polymyositis	O
who	O
presents	O
2	O
months	O
of	O
progressive	O
proximal	O
weakness	O
and	O
2	O
days	O
of	O
dyspnea	O
on	O
exertion.	O
History	O
is	O
provided	O
by	O
the	O
patient,	O
who	O
is	O
a	O
retired	O
ICU	O
___.	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
Muscle	O
biopsy	O
of	O
right	O
deltoid	O
___	O
FNA	O
right	O
cervical	O
lymph	O
node	O
___	O
Breast,	O
core	O
biopsy	O
___	O
Lumbar	O
puncture	O
___	O
Endometrial	O
biopsy	O
___	O
History	O
of	O
Present	O
Illness:	O
___	O
is	O
a	O
___	O
woman	O
with	O
a	O
history	O
of	O
HTN,	O
HLD,	O
a-fib	O
s/p	O
ablation,	O
Hashimoto's	O
thyroiditis,	O
and	O
recent	O
diagnosis	O
of	O
polymyositis	O
who	O
presents	O
2	O
months	O
of	O
progressive	O
proximal	O
weakness	O
and	O
2	O
days	O
of	O
dyspnea	O
on	O
exertion.	O
History	O
is	O
provided	O
by	O
the	O
patient,	O
who	O
is	O
a	O
retired	O
ICU	O
___.	O
Near	O
the	O
end	O
of	O
___	O
she	O
had	O
been	O
in	O
her	O
usual	O
state	O
of	O
health	O
and	O
was	O
doing	O
housework,	O
when	O
her	O
left	O
arm	O
became	O
very	O
weak	O
at	O
the	O
shoulder	O
and	O
she	O
was	O
unable	O
to	O
lift	O
it	O
appreciably.	O
It	O
had	O
been	O
completely	O
normal	O
earlier	O
in	O
the	O
day,	O
but	O
she	O
now	O
had	O
to	O
prop	O
her	O
arm	O
up	O
against	O
the	O
wall	O
to	O
put	O
on	O
deodorant,	O
for	O
example.	O
Her	O
strength	O
was	O
preserved	O
in	O
her	O
biceps,	O
triceps,	O
wrist,	O
and	O
hand.	O
She	O
went	O
to	O
a	O
___	O
clinic	O
where	O
X-rays	O
were	O
performed.	O
She	O
was	O
told	O
her	O
"shoulder	O
and	O
neck	O
were	O
a	O
mess"	O
and	O
given	O
a	O
7	O
day	O
taper	O
of	O
prednisone,	O
reportedly	O
to	O
treat	O
a	O
musculoskeletal	O
etiology.	O
She	O
saw	O
her	O
PCP	O
in	O
the	O
beginning	O
of	O
___	O
who	O
thought	O
it	O
might	O
be	O
a	O
radiculopathy.	O
He	O
ordered	O
an	O
MRI,	O
which	O
diagnosed	O
degenerative	O
joint	O
disease,	O
so	O
she	O
is	O
referred	O
to	O
a	O
neurosurgeon.	O
The	O
neurosurgeon	O
assessed	O
that	O
the	O
problem	O
was	O
in	O
the	O
shoulder,	O
not	O
in	O
the	O
neck,	O
and	O
referred	O
her	O
to	O
a	O
neurologist.	O
A	O
few	O
days	O
later,	O
she	O
also	O
began	O
to	O
develop	O
weakness	O
in	O
her	O
left	O
leg.	O
She	O
could	O
no	O
longer	O
get	O
off	O
the	O
toilet	O
or	O
out	O
of	O
bed	O
herself.	O
Her	O
husband	O
had	O
to	O
lift	O
her	O
and	O
help	O
to	O
get	O
dressed.	O
Her	O
neurologist	O
(Dr.	O
___	O
___	O
suspected	O
myasthenia	O
___,	O
and	O
ordered	O
a	O
nerve	O
conduction	O
study/EMG,	O
the	O
results	O
of	O
which	O
suggested	O
polymyositis.	O
She	O
was	O
also	O
told	O
that	O
she	O
had	O
rheumatoid	O
arthritis	O
and	O
Sjogren's	O
(though	O
this	O
may	O
mean,	O
rather,	O
that	O
she	O
was	O
positive	O
for	O
rheumatoid	O
factor	O
and	O
___.	O
She	O
had	O
an	O
elevated	O
CPK.	O
She	O
was	O
also	O
reportedly	O
MUSK	O
positive.	O
She	O
says	O
she	O
has	O
many	O
other	O
labs	O
pending	O
from	O
___.	O
Around	O
this	O
time	O
in	O
early	O
___,	O
her	O
hearing	B-Hearing_impairment
acutely	O
worsened.	B-Hearing_impairment
She	O
noticed	O
it	O
very	O
suddenly	O
one	O
day	O
while	O
out	O
with	O
her	O
husband	O
--	O
it	O
had	O
been	O
normal	O
in	O
the	O
morning,	O
and	O
significantly	O
worsened	O
suddenly	O
after	O
they	O
got	O
home.	B-Lives_alone
She	O
also	O
began	O
to	O
have	O
dry	O
mouth.	O
Towards	O
the	O
end	O
of	O
___,	O
she	O
noticed	O
some	O
weakness	O
in	O
both	O
hands	O
and	O
was	O
having	O
difficulty	O
holding	O
plates	O
when	O
she	O
was	O
washing	O
the	O
dishes.	O
Her	O
right	O
leg	O
also	O
started	O
to	O
become	O
weak.	O
In	O
the	O
beginning	O
of	O
___	O
she	O
was	O
eating	O
___	O
toast	O
cut	O
up	O
into	O
small	O
pieces,	O
and	O
it	O
became	O
stuck	O
high	O
in	O
her	O
esophagus.	O
Though	O
this	O
may	O
have	O
been	O
partly	O
associated	O
with	O
her	O
dry	O
mouth,	O
she	O
would	O
also	O
cough	O
when	O
drinking	O
water.	O
She	O
has	O
since	O
been	O
taking	O
only	O
protein	O
shakes	O
and	O
thickened	O
slushies.	O
She	O
has	O
lost	O
31	O
lbs	O
since	O
___.	O
Her	O
neurologist	O
prescribed	O
her	O
a	O
17	O
day	O
course	O
of	O
prednisone	O
___.	O
It	O
started	O
at	O
60mg	O
daily	O
and	O
decreased	O
by	O
10mg	O
every	O
3	O
days.	O
She	O
took	O
her	O
final	O
dose	O
of	O
10mg	O
this	O
past	O
___.	O
Prior	O
to	O
this,	O
she	O
had	O
not	O
been	O
walking	O
at	O
all	O
since	O
her	O
symptoms	O
started.	O
She	O
had	O
been	O
using	O
a	O
wheelchair	B-Mobile_with_aid
and	O
her	O
husband's	O
constant	O
assistance.	B-Mobile_with_assistance
About	O
2	O
weeks	O
ago	O
(roughly	O
coinciding	O
with	O
the	O
steroid	O
course),	O
she	O
started	O
using	O
a	O
walker,	B-Mobile_with_aid
and	O
became	O
able	O
to	O
get	O
out	O
of	O
bed	O
and	O
off	O
of	O
a	O
toilet	O
on	O
her	O
own	O
(though	O
she	O
is	O
not	O
sure	O
how	O
much	O
of	O
this	O
is	O
from	O
improved	O
strength	O
vs	O
new	O
strategies).	O
Since	O
___	O
she	O
noticed	O
she	O
was	O
"grunting"	O
breathing	O
more	O
heavily	O
with	O
standing	O
and	O
activity.	O
She	O
also	O
felt	O
that	O
when	O
she	O
stood	O
for	O
too	O
long,	O
her	O
shoulders	O
became	O
uncomfortable,	O
feeling	O
like	O
they	O
were	O
just	O
"hanging	O
there".	O
(The	O
says	O
this	O
was	O
an	O
unusual	O
sensation,	O
but	O
doesn't	O
know	O
how	O
better	O
to	O
describe	O
it.)	O
Today	O
she	O
was	O
feeling	O
increasingly	O
weak,	O
and	O
felt	O
that	O
she	O
needed	O
IV	O
fluids	O
so	O
she	O
went	O
to	O
___.	O
She	O
was	O
subsequently	O
transferred	O
to	O
___.	O
Neuro	O
ROS:	O
+	O
Left	O
shoulder	O
weakness	O
(late	O
___	O
+	O
Left	O
leg	O
weakness	O
(early	O
___	O
+	O
Gait	O
difficulty	O
+	O
Decreased	B-Hearing_impairment
hearing	B-Hearing_impairment
(mid	O
___	O
+	O
Dry	O
mouth	O
(mid	O
___	O
+	O
Bilat.	O
hand	O
weakness	O
(late	O
___	O
+	O
Right	O
leg	O
weakness	O
(late	O
___	O
+	O
Dysphagia	O
(early	O
___	O
+	O
Shortness	O
of	O
breath	O
(___-)	O
-	O
No	O
headache,	O
loss	B-Visual_impairment
of	B-Visual_impairment
vision,	B-Visual_impairment
blurred	B-Visual_impairment
vision,	B-Visual_impairment
diplopia,	B-Visual_impairment
dysphagia,	O
lightheadedness,	O
vertigo,	O
tinnitus.	B-Hearing_impairment
No	O
difficulties	O
producing	O
or	O
comprehending	O
speech.	O
No	O
focal	O
numbness,	O
parasthesiae.	O
No	O
bowel	B-Faecal_incontinence
or	O
bladder	B-Urinary_incontinence
incontinence	B-Faecal_incontinence
or	O
retention.	O
General	O
ROS:	O
+	O
Weight	B-Weight_loss
loss	B-Weight_loss
(31	O
lbs	O
since	O
___	O
+	O
Shoulder	O
discomfort	O
"Just	O
hanging	O
there"	O
+	O
Chronic	O
knee	O
pain	O
-	O
No	O
recent	O
fever,	O
chills,	O
night	O
sweats.	O
No	O
chest	O
pain,	O
palpitations,	O
cough.	O
No	O
nausea,	O
vomiting,	O
diarrhea,	O
constipation	B-Constipation
or	O
abdominal	O
pain.	O
No	O
arthralgias,	O
myalgias,	O
or	O
rashes.	O
Past	O
Medical	O
History:	O
===	O
PMH:	O
Hyperlipidemia	O
Hypertension	O
Paroxysmal	O
a-fib	O
s/p	O
ablation	O
(___)	O
Gallstone	O
pancreatitis	O
s/p	O
ERCP	O
x3	O
(___)	O
___'s	O
thyroiditis,	O
adenomatous	O
thyroid	O
nodules	O
(___)	O
Bilateral	O
carpal	O
tunnel	O
s/p	O
R	O
microsurgery	O
Obstructive	O
sleep	O
apnea	O
(moderate	O
on	O
sleep	O
study	O
___	O
Parotid	O
gland	O
enlargement	O
(___)	O
Sjogren's	O
disease	O
Polymyositis	O
associated	O
with	O
collagen	O
vascular	O
disease	O
Rheumatoid	O
arthritis	O
DVT	O
after	O
pregnancy	O
(___)	O
Surgical	O
History	O
(Last	O
Verified	O
-	O
None	O
on	O
file):	O
Cholecystectomy	O
___	O
Ovarian	O
cyst	O
surgery	O
___	O
Carpal	O
tunnel	O
release	O
___	O
Atrial	O
ablation	O
___	O
Social	O
History:	O
___	O
Family	O
History:	O
Maternal	O
uncle	O
died	O
from	O
complications	O
of	O
myasthenia	O
___.	O
Older	O
brother	O
with	O
___	O
body	O
dementia.	B-Dementia
Multiple	O
family	O
members	O
w/	O
cancer:	O
daughter	O
w/	O
thyroid	O
cancer,	O
father	O
w/	O
colon	O
cancer,	O
grandfather	O
w/	O
unknown	O
cancer	O
Physical	O
Exam:	O
ON	O
ADMISSION	O
___	O
===	O
EXAM:	O
-Vitals:	O
T:98.8	O
BP:152/76	O
HR:99	O
RR:16	O
SaO2:100%	O
NIF	O
-25	O
(poor	O
effort)	O
VC	O
930	O
-General:	O
Awake,	O
cooperative,	O
NAD.	O
-HEENT:	O
NC/AT.	O
No	O
scleral	O
icterus	O
noted.	O
MMM.	O
No	O
lesions	O
noted	O
in	O
oropharynx.	O
-Neck:	O
Supple.	O
-Cardiac:	O
RRR.	O
Well	O
perfused.	O
-Pulmonary:	O
CTAB	O
without	O
R/R/W.	O
Breathing	O
comfortably	O
on	O
room	O
air.	O
-Abdomen:	O
Soft,	O
NT/ND.	O
-Extremities:	O
Bilateral	O
lower	O
extremity	O
pitting	O
edema.	O
-Skin:	O
No	O
rashes	O
or	O
other	O
lesions	O
noted.	O
NEUROLOGIC	O
EXAM:	O
-Mental	O
Status:	O
Alert,	O
oriented	B-Delirium
x	B-Delirium
3.	B-Delirium
Able	O
to	O
relate	O
history	O
without	O
difficulty.	O
Attentive,	O
able	O
to	O
name	O
___	O
backward	O
without	O
difficulty.	O
Language	O
is	O
fluent	O
with	O
intact	O
comprehension.	O
Normal	O
prosody.	O
There	O
are	O
no	O
paraphasic	O
errors.	O
Able	O
to	O
name	O
low	O
frequency	O
objects.	O
Able	O
to	O
read	O
without	O
difficulty.	O
Speech	O
is	O
not	O
dysarthric.	O
Able	O
to	O
follow	O
both	O
midline	O
and	O
appendicular	O
commands.	O
Able	O
to	O
register	O
3	O
objects	O
and	O
recall	O
___	O
at	O
5	O
minutes.	O
Had	O
good	O
knowledge	O
of	O
current	O
events.	O
There	O
is	O
no	O
evidence	O
of	O
apraxia	O
or	O
neglect.	O
-Cranial	O
Nerves:	O
I:	O
Olfaction	O
not	O
tested.	O
II:	O
PERRL	O
5	O
to	O
4mm	O
and	O
brisk.	O
VFF	O
to	O
confrontation	O
and	O
no	O
extinction.	O
III,	O
IV,	O
VI:	O
EOMI	O
without	O
nystagmus.	O
Normal	O
saccades.	O
No	O
diplopia,	B-Visual_impairment
dysconjugate	O
gaze,	O
or	O
ptosis	O
after	O
1	O
minute	O
sustained	O
upgaze.	O
V:	O
Facial	O
sensation	O
intact	O
to	O
light	O
touch.	O
Masseter	O
and	O
temporalis	O
contraction	O
barely	O
palpable.	O
VII:	O
No	O
facial	O
droop,	O
facial	O
musculature	O
symmetric.	O
VIII:	O
Unable	B-Hearing_impairment
to	B-Hearing_impairment
hear	B-Hearing_impairment
whispered	O
word	O
with	O
either	O
ear	O
covered.	O
Weber	O
localizes	O
to	O
left,	O
and	O
on	O
___	O
could	B-Hearing_impairment
not	B-Hearing_impairment
hear	B-Hearing_impairment
via	O
air	O
on	O
right,	O
suggesting	O
right	O
sensorineural	B-Hearing_impairment
hearing	B-Hearing_impairment
loss	B-Hearing_impairment
(or	O
bilateral	O
but	O
greater	O
on	O
right).	O
IX,	O
X:	O
Unable	O
to	O
visualize	O
palate.	O
XI:	O
___	O
strength	O
in	O
trapezii	O
and	O
SCM	O
bilaterally.	O
XII:	O
Unable	O
to	O
extend	O
tongue	O
more	O
than	O
1cm	O
outside	O
of	O
mouth.	O
Unable	O
to	O
put	O
tongue	O
in	O
either	O
cheek.	O
With	O
tongue	O
extended,	O
side-to-side	O
movement	O
noticeably	O
slowed.	O
*	O
Able	O
to	O
count	O
to	O
25	O
on	O
one	O
breath,	O
however	O
confounded	O
by	O
difficulty	O
articulating	O
quickly	O
due	O
to	O
dry	O
mouth	O
("My	O
tongue	O
was	O
stuck	O
to	O
my	O
mouth").	O
-Motor:	O
Normal	O
bulk,	O
tone	O
throughout.	O
No	O
pronator	O
drift	O
on	O
right	O
(unable	O
to	O
elevate	O
left	O
arm).	O
No	O
adventitious	O
movements,	O
such	O
as	O
tremor,	O
noted.	O
No	O
asterixis	O
noted.	O
Delt	O
Bic	O
Tri	O
WrE	O
FFl	O
FE	O
IO	O
IP	O
Quad	O
Ham	O
TA	O
___	O
L	O
2	O
___	O
___	O
2	O
4	O
4-	O
5	O
5	O
5	O
R	O
4-	O
4+	O
___	O
4+	O
___	O
4	O
5	O
5	O
5	O
*	O
Neck	O
flexors	O
4-	O
(can	O
overpower	O
with	O
2	O
fingers)	O
*	O
Neck	O
extensors	O
4	O
-Sensory:	O
No	O
deficits	O
to	O
light	O
touch,	O
cold	O
sensation,	O
or	O
pinprick	O
throughout.	O
Vibration	O
absent	O
at	O
ankles,	O
only	O
5	O
seconds	O
at	O
bilateral	O
patella,	O
and	O
10	O
seconds	O
at	O
MP	O
joints	O
in	O
both	O
hands.	O
No	O
extinction	O
to	O
DSS.	O
-DTRs:	O
Bi	O
Tri	O
___	O
Pat	O
Ach	O
Toes	O
L	O
1+	O
1+	O
Tr	O
1+	O
Down	O
R	O
1+	O
1+	O
Tr	O
1+	O
Down	O
-Coordination:	O
Rapid	O
finger	O
and	O
toe	O
tapping	O
with	O
good	O
speed	O
and	O
cadence	O
bilaterally.	O
FNF	O
intact	O
on	O
right,	O
unable	O
to	O
assess	O
on	O
left	O
due	O
to	O
weakness.	O
-Gait:	O
Deferred.	O
TODAY	O
___	O
Exam:	O
-VS:	O
AF,	O
BP	O
149/67,	O
HR	O
90,	O
RR	O
21,	O
SpO2	O
99	O
RA	O
-General:	O
Awake,	O
cooperative,	O
NAD.	O
Speaking	O
in	O
full	O
sentences,	O
voice	O
stronger	O
and	O
less	O
coarse	O
than	O
on	O
admission	O
-HEENT:	O
NC/AT.	O
No	O
scleral	O
icterus	O
noted.	O
MMM.	O
-Neck:	O
Palpable	O
lymph	O
node	O
in	O
the	O
supraclavicular	O
region	O
on	O
the	O
R	O
side	O
-Cardiac:	O
RRR,	O
appears	O
well	O
perfused	O
-Pulmonary:	O
Breathing	O
comfortably	O
on	O
room	O
air	O
at	O
rest	O
-Abdomen:	O
Not	O
distended	O
-Extremities:	O
Increased	O
bilateral	O
3+	O
lower	O
extremity	O
pitting	O
edema.	O
-Skin:	O
No	O
rashes	O
NEUROLOGIC	O
EXAM:	O
-Mental	O
Status:	O
Alert,	O
oriented	B-Delirium
x	B-Delirium
4.	B-Delirium
Able	O
to	O
relate	O
history	O
without	O
difficulty.	O
Language	O
is	O
fluent	O
with	O
intact	O
comprehension.	O
Normal	O
prosody.	O
There	O
are	O
no	O
paraphasic	O
errors.	O
Speech	O
is	O
not	O
dysarthric.	O
Able	O
to	O
follow	O
both	O
midline	O
and	O
appendicular	O
commands.	O
There	O
is	O
no	O
evidence	O
of	O
apraxia	O
or	O
neglect.	O
-Cranial	O
Nerves:	O
II:	O
Normal.	O
III,	O
IV,	O
VI:	O
EOMI,	O
PERRL	O
8	O
to	O
6mm	O
b/l,	O
conjugate	O
gaze,	O
no	O
nystagmus,	O
no	O
square	O
wave	O
in	O
primary	O
gaze	O
V:	O
Facial	O
sensation	O
intact	O
to	O
light	O
touch	O
throughout.	O
VII:	O
Can	O
puff	O
out	O
cheeks,	O
has	O
difficulty	O
pocketing	O
air,	O
tongue	O
in	O
cheek	O
stronger	O
than	O
previously	O
VIII:	O
Bilateral	O
low	O
and	O
high	O
pitch	O
hearing	B-Hearing_impairment
loss	B-Hearing_impairment
-	O
painless,	O
significantly	O
more	O
pronounced	O
on	O
the	O
R	O
side.	O
IX,	O
X:	O
Gag	O
reflex	O
present.	O
Palate	O
elevates	O
symmetrically.	O
XI:	O
___	O
strength	O
in	O
trapezii	O
bilaterally.	O
___	O
strength	O
in	O
SCM	O
bilaterally.	O
XII:	O
Can	O
protrude	O
tongue	O
out	O
further	O
than	O
on	O
admission(~1inch).	O
Can	O
put	O
tongue	O
in	O
cheek	O
bilaterally.	O
-Motor:	O
Normal	O
bulk,	O
tone	O
throughout.	O
Unable	O
to	O
test	O
for	O
pronator	O
drift	O
given	O
proximal	O
muscle	O
weakness,	O
patient	O
unable	O
to	O
elevate	O
arm.	O
No	O
adventitious	O
movements,	O
such	O
as	O
tremor,	O
noted.	O
No	O
asterixis	O
noted.	O
-Strength:	O
Bic	O
Tri	O
Delt	O
WrE	O
FFl	O
FE	O
IO	O
IP	O
Quad	O
Ham	O
TA	O
___	O
L	O
5	O
___	O
4-	O
___	O
4+	O
4+	O
5	O
5	O
5	O
R	O
5	O
___	O
4-	O
4+	O
___-	O
___	O
5	O
Neck	O
extensors	O
5-,	O
neck	O
flexors	O
4	O
able	O
to	O
lift	O
head	O
off	O
pillow	O
for	O
3	O
seconds	O
Finger	O
extensors	O
___	O
b/l.	O
-Sensory:	O
Not	O
tested	O
today.	O
-DTRs:	O
Bi	O
Tri	O
___	O
Pat	O
Ach	O
Toes	O
L	O
1+	O
1+	O
1+	O
2	O
1+	O
Down	O
R	O
2	O
2	O
2	O
2	O
1+	O
Down	O
-Coordination:	O
Rapid	O
finger	O
and	O
toe	O
tapping	O
with	O
good	O
speed	O
and	O
cadence	O
bilaterally.	O
Unable	O
to	O
assess	O
FNF	O
given	O
patient's	O
proximal	O
muscle	O
weakness.	O
-Gait:	O
Deferred,	O
patient	O
too	O
weak	O
to	O
ambulate.	O
DISCHARGE	O
EXAM:	O
================	O
VITALS:	O
97.3	O
PO|	O
134	O
/	O
60|	O
92|	O
20|	O
96	O
RA	O
General:	O
Obese,	O
alert	O
and	O
cooperative,	O
and	O
appears	O
to	O
be	O
in	O
no	O
acute	O
distress.	O
HEENT:	O
Normocephalic,	O
atraumatic.	O
Pupils	O
are	O
equal,	O
round,	O
and	O
reactive	O
to	O
light	O
and	O
accommodation	O
constricting	O
from	O
3.5	O
mm	O
to	O
3mm	O
bilaterally.	O
EOMI	O
in	O
all	O
cardinal	O
directions	O
of	O
gaze	O
without	O
nystagmus.	O
Vision	B-Visual_impairment
is	O
grossly	O
intact.	B-Hearing_impairment
Hard	B-Hearing_impairment
of	B-Hearing_impairment
hearing,	B-Hearing_impairment
right	O
ear	O
worse	O
than	O
left.	O
Nares	O
patent	O
with	O
no	O
nasal	O
discharge,	O
NG	O
tube	O
in	O
place.	O
Oral	O
cavity	O
and	O
pharynx	O
are	O
without	O
inflammation,	O
swelling,	O
exudate,	O
or	O
lesions.	O
Teeth	O
and	O
gingiva	O
in	O
good	O
general	O
condition.	O
Neck:	O
Neck	O
supple,	O
non-tender,	O
with	O
anterior	O
cervical	O
lymphadenopathy,	O
no	O
masses	O
or	O
thyromegaly.	O
Cardiac:	O
Normal	O
S1	O
and	O
S2.	O
No	O
S3,	O
S4	O
or	O
murmurs.	O
Rhythm	O
is	O
regular.	O
Pulmonary:	O
Clear	O
to	O
auscultation	O
without	O
rales,	O
rhonchi,	O
wheezing	O
or	O
diminished	O
breath	O
sounds.	O
Abdomen:	O
Normoactive	O
bowel	O
sounds.	O
Ecchymoses	O
on	O
abdomen.	O
Soft,	O
nondistended,	O
nontender.	O
No	O
guarding	O
or	O
rebound.	O
No	O
masses.	O
Musculoskeletal:	O
No	O
joint	O
erythema	O
or	O
tenderness.	O
Muscle	O
bulk	O
and	O
tone	O
appropriate	O
for	O
age	O
and	O
habitus.	O
1+	O
___	O
edema.	O
Neuro:	O
Mental	O
Status:	O
Alert	O
and	O
oriented	B-Delirium
x3.	B-Delirium
CN	O
II-XII	O
intact.	O
Psych:	O
Appropriate	O
mood	O
and	O
affect.	O
Skin:	O
Skin	O
type	O
II.	O
Erythematous	O
vesicles	O
and	O
plaques	O
with	O
excoriation	O
on	O
abdomen	O
adjacent	O
to	O
telemetry	O
stickers.	O
Ecchymoses	O
and	O
purpura	O
over	O
extremities	O
and	O
pannus.	O
Pertinent	O
Results:	O
___	O
09:30PM	O
PLT	O
COUNT-134*	O
___	O
09:30PM	O
NEUTS-82.0*	O
LYMPHS-8.6*	O
MONOS-6.4	O
EOS-1.2	O
BASOS-0.6	O
IM	O
___	O
AbsNeut-5.65	O
AbsLymp-0.59*	O
AbsMono-0.44	O
AbsEos-0.08	O
AbsBaso-0.04	O
___	O
09:30PM	O
WBC-6.9	O
RBC-5.03	O
HGB-14.3	O
HCT-44.2	O
MCV-88	O
MCH-28.4	O
MCHC-32.4	O
RDW-16.6*	O
RDWSD-52.6*	O
___	O
09:30PM	O
C3-117	O
C4-45*	O
___	O
09:30PM	O
dsDNA-NEGATIVE	O
___	O
09:30PM	O
CK(CPK)-111	O
___	O
09:30PM	O
estGFR-Using	O
this	O
___	O
09:30PM	O
GLUCOSE-84	O
UREA	O
N-12	O
CREAT-0.7	O
SODIUM-139	O
POTASSIUM-4.1	O
CHLORIDE-98	O
TOTAL	O
CO2-21*	O
ANION	O
GAP-20*	O
___	O
01:55AM	O
URINE	O
MUCOUS-OCC*	O
___	O
01:55AM	O
URINE	O
RBC-9*	O
WBC->182*	O
BACTERIA-MANY*	O
YEAST-NONE	O
EPI-23	O
TRANS	O
EPI-<1	O
___	O
01:55AM	O
URINE	O
BLOOD-SM*	O
NITRITE-NEG	O
PROTEIN-30*	O
GLUCOSE-NEG	O
KETONE-40*	O
BILIRUBIN-NEG	O
UROBILNGN-NEG	O
PH-6.0	O
LEUK-LG*	O
___	O
01:55AM	O
URINE	O
COLOR-Yellow	O
APPEAR-Hazy*	O
SP	O
___	O
___	O
01:55AM	O
URINE	O
UHOLD-HOLD	O
___	O
01:55AM	O
URINE	O
HOURS-RANDOM	O
___	O
01:10PM	O
LUPUS-NEG	O
___	O
01:10PM	O
___	O
PTT-26.4	O
___	O
___	O
01:10PM	O
C3-113	O
C4-42*	O
___	O
01:10PM	O
CRP-13.5*	O
dsDNA-NEGATIVE	O
___	O
09:50PM	O
PLT	O
COUNT-120*	O
___	O
09:50PM	O
WBC-7.1	O
RBC-5.03	O
HGB-14.6	O
HCT-45.0	O
MCV-90	O
MCH-29.0	O
MCHC-32.4	O
RDW-16.9*	O
RDWSD-53.6*	O
___	O
09:50PM	O
VoidSpec-UNLABELED	O
___	O
09:50PM	O
___	O
TITER-1:320*	O
___	O
09:50PM	O
ANCA-NEGATIVE	O
B	O
___	O
09:50PM	O
TSH-0.77	O
___	O
09:50PM	O
ALBUMIN-3.1*	O
CALCIUM-8.7	O
PHOSPHATE-3.4	O
MAGNESIUM-2.0	O
___	O
09:50PM	O
CK-MB-11*	O
MB	O
INDX-7.7*	O
cTropnT-.14*	O
___	O
09:50PM	O
LIPASE-26	O
___	O
09:50PM	O
ALT(SGPT)-18	O
AST(SGOT)-56*	O
LD(LDH)-673*	O
CK(CPK)-143	O
ALK	O
PHOS-65	O
TOT	O
BILI-0.6	O
___	O
09:50PM	O
GLUCOSE-76	O
UREA	O
N-12	O
CREAT-0.8	O
SODIUM-139	O
POTASSIUM-4.9	O
CHLORIDE-98	O
TOTAL	O
CO2-17*	O
ANION	O
GAP-24*	O
___	O
11:10PM	O
URINE	O
MUCOUS-RARE*	O
___	O
11:10PM	O
URINE	O
HYALINE-5*	O
WAXY-1*	O
___	O
11:10PM	O
URINE	O
RBC-0	O
WBC-2	O
BACTERIA-MANY*	O
YEAST-NONE	O
EPI-0	O
___	O
11:10PM	O
URINE	O
BLOOD-NEG	O
NITRITE-NEG	O
PROTEIN-TR*	O
GLUCOSE-NEG	O
KETONE-40*	O
BILIRUBIN-NEG	O
UROBILNGN-NEG	O
PH-5.5	O
LEUK-TR*	O
___	O
11:10PM	O
URINE	O
COLOR-Yellow	O
APPEAR-Clear	O
SP	O
___	O
___	O
11:10PM	O
URINE	O
HOURS-RANDOM	O
CREAT-126	O
TOT	O
PROT-24	O
PROT/CREA-0.2	O
___	O
09:30AM	O
BLOOD	O
WBC-6.7	O
RBC-3.96	O
Hgb-11.3#	O
Hct-35.2	O
MCV-89	O
MCH-28.5	O
MCHC-32.1	O
RDW-16.6*	O
RDWSD-53.2*	O
Plt	O
___	O
___	O
08:05AM	O
BLOOD	O
WBC-5.5	O
RBC-4.03	O
Hgb-11.6	O
Hct-36.4	O
MCV-90	O
MCH-28.8	O
MCHC-31.9*	O
RDW-16.8*	O
RDWSD-55.0*	O
Plt	O
___	O
___	O
06:20AM	O
BLOOD	O
WBC-4.8	O
RBC-3.85*	O
Hgb-10.9*	O
Hct-34.2	O
MCV-89	O
MCH-28.3	O
MCHC-31.9*	O
RDW-16.6*	O
RDWSD-53.3*	O
Plt	O
Ct-83*	O
___	O
06:25AM	O
BLOOD	O
WBC-5.0	O
RBC-3.80*	O
Hgb-10.8*	O
Hct-33.8*	O
MCV-89	O
MCH-28.4	O
MCHC-32.0	O
RDW-16.5*	O
RDWSD-53.6*	O
Plt	O
___	O
___	O
07:45AM	O
BLOOD	O
WBC-5.5	O
RBC-3.96	O
Hgb-11.3	O
Hct-35.3	O
MCV-89	O
MCH-28.5	O
MCHC-32.0	O
RDW-16.9*	O
RDWSD-54.1*	O
Plt	O
___	O
___	O
07:45AM	O
BLOOD	O
Neuts-85.2*	O
Lymphs-6.3*	O
Monos-6.3	O
Eos-0.2*	O
Baso-0.2	O
Im	O
___	O
AbsNeut-4.71	O
AbsLymp-0.35*	O
AbsMono-0.35	O
AbsEos-0.01*	O
AbsBaso-0.01	O
___	O
07:45AM	O
BLOOD	O
___	O
PTT-26.0	O
___	O
___	O
07:45AM	O
BLOOD	O
Plt	O
___	O
___	O
07:45AM	O
BLOOD	O
Glucose-200*	O
UreaN-23*	O
Creat-0.6	O
Na-137	O
K-4.0	O
Cl-97	O
HCO3-27	O
AnGap-13	O
___	O
07:45AM	O
BLOOD	O
ALT-55*	O
AST-65*	O
LD(LDH)-369*	O
AlkPhos-64	O
TotBili-0.4	O
___	O
06:45AM	O
BLOOD	O
cTropnT-0.09*	O
___	O
07:45AM	O
BLOOD	O
Albumin-2.5*	O
Calcium-8.5	O
Phos-2.9	O
Mg-2.1	O
UricAcd-4.5	O
___	O
06:25AM	O
BLOOD	O
calTIBC-153*	O
Ferritn-469*	O
TRF-118*	O
___	O
08:05AM	O
BLOOD	O
PARANEOPLASTIC	O
AUTOANTIBODY	O
EVALUATION-PND	O
___	O
12:50PM	O
BLOOD	O
HEPARIN	O
DEPENDENT	O
ANTIBODIES-PND	O
INTERVAL	O
STUDIES:	O
ECHO	O
___:	O
IMPRESSION:	O
Suboptimal	O
image	O
quality.	O
Mild	O
symmetric	O
left	O
ventricular	O
hypertrophy	O
with	O
preserved	O
regional/global	O
systolic	O
function.	O
Mild	O
pulmonary	O
artery	O
systolic	O
hypertension.	O
PELVIS	O
US	O
___	O
1.	O
Heterogeneous	O
enlarged	O
endometrium	O
with	O
internal	O
cystic	O
spaces.	O
Biopsy	O
is	O
recommended.	O
2.	O
1	O
cm	O
simple	O
appearing	O
right	O
ovarian	O
cyst	O
for	O
which	O
___	O
year	O
follow-up	O
pelvic	O
ultrasound	O
is	O
recommended.	O
DISCHARGE	O
LABS:	O
===============	O
___	O
05:45AM	O
BLOOD	O
WBC-4.4	O
RBC-3.31*	O
Hgb-9.9*	O
Hct-29.5*	O
MCV-89	O
MCH-29.9	O
MCHC-33.6	O
RDW-16.5*	O
RDWSD-53.8*	O
Plt	O
___	O
___	O
05:45AM	O
BLOOD	O
Neuts-88.7*	O
Lymphs-8.6*	O
Monos-0.9*	O
Eos-1.1	O
Baso-0.2	O
Im	O
___	O
AbsNeut-3.94	O
AbsLymp-0.38*	O
AbsMono-0.04*	O
AbsEos-0.05	O
AbsBaso-0.01	O
___	O
05:45AM	O
BLOOD	O
Glucose-167*	O
UreaN-33*	O
Creat-0.8	O
Na-138	O
K-3.5	O
Cl-89*	O
HCO3-31	O
AnGap-18	O
___	O
05:45AM	O
BLOOD	O
ALT-77*	O
AST-66*	O
LD(LDH)-398*	O
AlkPhos-74	O
TotBili-0.5	O
___	O
05:45AM	O
BLOOD	O
TotProt-6.3*	O
Albumin-3.5	O
Globuln-2.8	O
Calcium-9.0	O
Phos-2.7	O
Mg-2.2	O
Brief	O
Hospital	O
Course:	O
#Progressive	O
severe	O
proximal	O
muscle	O
weakness,	O
initially	O
also	O
with	O
question	O
of	O
bulbar	O
involvement:	O
On	O
admission	O
patient	O
was	O
also	O
continued	O
on	O
prednisone	O
10mg	O
daily	O
(prednisone	O
was	O
started	O
by	O
the	O
outpatient	O
Neurologist	O
on	O
___	O
for	O
the	O
muscle	O
weakness,	O
initially	O
at	O
60mg	O
daily,	O
then	O
tapered	O
to	O
10mg	O
daily.	O
It	O
was	O
increased	O
to	O
60mg	O
on	O
___	O
given	O
patients	O
respiratory	O
status,	O
low	O
NIF's	O
-20	O
to	O
-30	O
and	O
VC	O
~	O
1L.	O
She	O
was	O
also	O
started	O
on	O
IVIG	O
25mg	O
daily	O
x	O
5	O
days	O
___	O
(~2g/kg	O
divided	O
into	O
5	O
days).	O
Rheumatology	O
was	O
consulted	O
and	O
following.	O
Patient	O
underwent	O
an	O
extensive	O
work-up	O
including	O
autoimmune,	O
inflammatory,	O
demeylinating,	O
and	O
neoplastic	O
origin.	O
CK	O
was	O
elevated	O
(143),	O
CRP	O
13.5,	O
ESR	O
29,	O
___	O
titers	O
were	O
strongly	O
positive	O
(1:320),	O
dsDNA	O
negative,	O
lupus	O
anticoagulant	O
negative,	O
B2	O
GLYCOPROTEIN	O
I	O
IgG/IgM/IgA	O
neg,	O
ANCA	O
NEGATIVE,	O
cardiolipin	O
Ab	O
IgG	O
negative;	O
however,	O
cardiolipin	O
Ab	O
IgM	O
was	O
elevated	O
(placing	O
the	O
patient	O
in	O
the	O
intermiediate	O
catergory),	O
SJOGREN'S	O
ANTIBODY	O
(SS-A)>8.0	O
positive,	O
and	O
SJOGREN'S	O
ANTIBODY	O
(SS-B)	O
<1.0	O
negative.	O
___.	O
Given	O
positivity	O
to	O
multiple	O
serologic	O
symptoms,	O
patient's	O
serologic	O
studies	O
are	O
most	O
consistent	O
with	O
an	O
overlap	O
syndrome.	O
Additionally	O
to	O
the	O
labs	O
listed	O
above,	O
serum	O
myositis	O
antibody	O
profile	O
was	O
sent	O
and	O
is	O
still	O
pending,	O
aldolase	O
is	O
10.2	O
(elevated)	O
-	O
which	O
would	O
be	O
expected	O
in	O
diseases	O
affecting	O
the	O
muscle,	O
C3	O
WNL,	O
C4	O
only	O
minimally	O
elevated.	O
Paraneoplastic	O
panel	O
was	O
added	O
to	O
the	O
serum	O
sample	O
from	O
___	O
(oldest	O
available,	O
but	O
after	O
2	O
doses	O
of	O
IVIG).	O
EMG	O
done	O
on	O
___	O
was	O
abnormal,	O
showed	O
moderate-to-severe,	O
generalized	O
myopathy	O
with	O
associated	O
denervating	O
features,	O
as	O
seen	O
in	O
inflammatory	O
myositis.	O
R	O
deltoid	O
muscle	O
biopsy	O
was	O
completed	O
on	O
___,	O
final	O
read	O
pending;	O
however,	O
per	O
prelim	O
interpretation	O
by	O
Dr.	O
___	O
biopsied	O
tissue	O
is	O
notable	O
for	O
mild-non	O
specific	O
changes,	O
no	O
obvious	O
inflammation.	O
MRI	O
Brain	O
w/	O
brainstem	O
cuts	O
was	O
performed	O
due	O
to	O
concern	O
for	O
bulbar	O
involvement	O
and	O
it	O
was	O
unremarkable.	O
Given	O
that	O
paraneoplastic	O
syndrome	O
was	O
on	O
the	O
differential,	O
CT	O
of	O
the	O
torso	O
was	O
performed	O
to	O
rule	O
out	O
malignancy,	O
it	O
revealed	O
enlarged	O
cervical	O
lymph	O
node	O
at	O
the	O
base	O
of	O
the	O
neck	O
on	O
the	O
R	O
side,	O
the	O
lesion	O
was	O
biopsied	O
by	O
FNA	O
and	O
was	O
positive	O
for	O
metastatic	O
carcinoma,	O
primary	O
tumor	O
site	O
unclear	O
(see	O
details	O
regarding	O
further	O
work-up	O
below).	O
Neurologically,	O
patient	O
has	O
shown	O
significant	O
improvement	O
in	O
strength	O
and	O
continues	O
to	O
improve,	O
hearing	O
loss	O
on	O
the	O
R	O
side	O
improved.	O
#	O
Enlarged	O
lymph	O
node	O
w/	O
poorly	O
differentiated	O
carcinoma	O
CT	O
of	O
the	O
torso	O
on	O
___	O
demonstrated	O
a	O
3cmx2.9cm	O
R	O
cervical	O
lymph	O
node	O
at	O
5b	O
level,	O
nonspecific	O
enlarged	O
celiac	O
and	O
porta	O
hepatis	O
lymph	O
nodes	O
with	O
celiac	O
node	O
measuring	O
up	O
to	O
28	O
x	O
12	O
mm,	O
and	O
1	O
x	O
0.9	O
cm	O
soft	O
tissue	O
lesion	O
is	O
seen	O
within	O
the	O
upper	O
inner	O
right	O
breast,	O
no	O
other	O
findings	O
concerning	O
for	O
malignancy	O
noted.	O
CT	O
Neck	O
___:	O
redemonstrated	O
enlarged	O
lymph	O
node	O
on	O
the	O
R	O
side	O
at	O
the	O
base	O
of	O
the	O
neck:	O
28mmx30mmx28mm	O
(5b	O
level).	O
The	O
R	O
neck	O
lymph	O
node	O
was	O
biopsied	O
by	O
FNA	O
on	O
___	O
and	O
it	O
was	O
positive	O
for	O
malignant	O
cells	O
consistent	O
with	O
poorly	O
differentiated	O
carcinoma.	O
Hem-Onc	O
was	O
consulted	O
and	O
recommended	O
further	O
investigation	O
to	O
identify	O
the	O
primary	O
tumor.	O
Differential	O
diagnosis	O
includes	O
luminal	O
lesions	O
not	O
visualized	O
on	O
CT	O
such	O
as	O
colon/gastric	O
cancer,	O
as	O
well	O
as	O
breast	O
cancer,	O
head/neck	O
cancer.	O
Family	O
Hx	O
is	O
notable	O
for	O
colon	O
cancer	O
and	O
her	O
last	O
colonoscopy	O
was	O
many	O
years	O
ago.	O
She	O
was	O
doing	O
fecal	O
occult	O
testing	O
yearly	O
which	O
was	O
always	O
negative,	O
last	O
one	O
about	O
___	O
years	O
ago.	O
GI	O
was	O
consulted	O
for	O
EGD	O
and	O
EUS	O
biopsy	O
of	O
celiac	O
LN	O
as	O
this	O
is	O
the	O
only	O
other	O
area	O
of	O
concern	O
on	O
imaging.	O
Plan	O
for	O
procedures	O
___,	O
bowel	O
prep	O
on	O
___.	O
Also	O
checking	O
iron	O
studies	O
(iron,	O
ferritin,	O
TIBC)	O
since	O
iron	O
deficiency	O
may	O
be	O
related	O
to	O
GI	O
malignancy	O
and	O
chronic	O
blood	O
loss.	O
LDH	O
elevated,	O
uric	O
acid	O
sent	O
and	O
pending.	O
The	O
location	O
of	O
her	O
node	O
in	O
the	O
posterior	O
triangle	O
at	O
level	O
5b	O
could	O
also	O
be	O
suspicious	O
for	O
head/neck	O
cancer	O
or	O
thyroid	O
cancer.	O
Laryngeal	O
ca	O
can	O
present	O
should	O
be	O
considered	O
if	O
nothing	O
is	O
found	O
on	O
GI	O
tract	O
exploration.	O
Considering	O
her	O
history	O
of	O
___'s	O
thyroiditis,	O
she	O
is	O
at	O
increased	O
risk	O
for	O
thyroid	O
lymphoma	O
and	O
papillary	O
thyroid	O
cancer,	O
but	O
these	O
would	O
tend	O
to	O
be	O
more	O
indolent,	O
and	O
no	O
concerning	O
lesions	O
were	O
found	O
on	O
CT	O
neck.	O
Of	O
note,	O
patient	O
has	O
a	O
lesion	O
in	O
the	O
R	O
breast,	O
which	O
was	O
followed	O
by	O
serial	O
ultrasounds	O
and	O
mammograms,	O
per	O
patient	O
previously	O
identified	O
as	O
benign	O
cystic	O
lesion,	O
no	O
records	O
available	O
for	O
review	O
yet.	O
Given	O
the	O
history	O
and	O
newly	O
found	O
lymph	O
node	O
with	O
evidence	O
of	O
matastatic	O
disease,	O
decision	O
was	O
made	O
to	O
repeat	O
mammogram	O
(despite	O
the	O
fact	O
that	O
last	O
one	O
was	O
completed	O
in	O
___	O
-	O
reportedly	O
unchanged).	O
However,	O
unable	O
to	O
complete	O
mammogram	O
since	O
patient	O
unable	O
to	O
stand.	O
Unilateral	O
US	O
of	O
the	O
breast	O
was	O
completed	O
and	O
showed	O
solid	O
lesion,	O
core	O
biopsy	O
was	O
completed	O
and	O
specimen	O
was	O
sent	O
to	O
Pathology.	O
Surgery	O
also	O
consulted	O
for	O
potential	O
excisional	O
biopsy	O
of	O
the	O
R	O
neck	O
lymph	O
node	O
per	O
Hem-Onc	O
recs;	O
however,	O
will	O
___	O
until	O
completion	O
of	O
endoscopic	O
GI	O
procedures.	O
If	O
nothing	O
is	O
found	O
on	O
GI	O
scopes,	O
would	O
consider	O
having	O
ENT	O
perform	O
laryngoscopy	O
to	O
assess	O
for	O
head/neck	O
cancer	O
Subsequently	O
the	O
patient	O
was	O
found	O
to	O
have	O
elevated	O
CA	O
125	O
and	O
preliminary	O
pathology	O
from	O
celiac	O
node	O
biopsy	O
consistent	O
with	O
GYN	O
primary	O
from	O
Mullerian	O
origin.	O
Gyn	O
onc	O
was	O
consulted	O
and	O
recommended	O
chemotherapy,	O
and	O
no	O
need	O
for	O
surgical	O
staging	O
at	O
this	O
point.	O
Imaging	O
was	O
only	O
remarkable	O
for	O
endometrial	O
thickening	O
on	O
pelvic	O
ultrasound.	O
Patient	O
was	O
presented	O
at	O
tumor	O
board	O
and	O
decision	O
was	O
made	O
to	O
treat	O
with	O
****.	O
The	O
patient	O
also	O
underwent	O
lumbar	O
puncture	O
to	O
rule	O
out	O
leptomeningeal	O
carcinomatosis,	O
which	O
revealed	O
CSF	O
with	O
no	O
malignant	O
cells.	O
Patient	O
began	O
chemotherapy	O
C1D1	O
___	O
on	O
___.	O
#	O
Respiratory	O
weakness	O
Patient	O
monitored	O
in	O
NIMU	O
throughout	O
admission,	O
Q6H	O
NIF/VC.	O
NIF's	O
ranged	O
from	O
-30	O
to	O
-12,	O
VC	O
.___,	O
but	O
improved	O
to	O
-35	O
to	O
-20	O
at	O
time	O
of	O
transfer	O
to	O
the	O
OMED	O
service.	O
Prior	O
EMG	O
concerning	O
for	O
polymyositis.	O
However,	O
muscle	O
bx	O
from	O
___	O
with	O
prelim	O
read	O
showing	O
mild-non	O
specific	O
changes,	O
no	O
obvious	O
inflammation.	O
Overall,	O
the	O
clinical	O
presentation	O
consistent	O
with	O
probable	O
paraneoplastic	O
syndrome.	O
So	O
far	O
rheum	O
workup	O
revealing	O
for	O
SSA	O
+	O
and	O
elevated	O
CRP.	O
Workup	O
thus	O
far	O
notable	O
for	O
enlarged	O
supraclavicular	O
cervical	O
LAD	O
w/	O
FNA	O
biopsy	O
revealing	O
malignant	O
cells	O
and	O
poorly	O
differentiated	O
carcinoma,	O
primary	O
unclear	O
&	O
celiac	O
and	O
porta	O
hepatis	O
LAD	O
on	O
abd	O
CT.	O
Now	O
with	O
elevated	O
CA	O
125	O
and	O
preliminary	O
pathology	O
from	O
celiac	O
node	O
biopsy	O
consistent	O
with	O
GYN	O
primary.	O
___	O
paraneoplastic	O
antibody	O
panel	O
notable	O
for	O
P/Q-type	O
calcium	O
channel	O
antibody	O
elevated	O
at	O
0.05	O
and	O
striated	O
muscle	O
antibody	O
positive	O
at	O
titer	O
of	O
1:7680,	O
both	O
of	O
which	O
are	O
consistent	O
with	O
presumed	O
paraneoplastic	O
syndrome.	O
There	O
is	O
at	O
least	O
one	O
case	O
report	O
of	O
myasthenia	O
___	O
in	O
a	O
patient	O
with	O
a	O
malignant	O
mixed	O
Mullerian	O
tumor	O
of	O
the	O
uterine	O
corpus	O
(Gynecology	O
Oncology,	O
___,	O
Volume	O
64,	O
Issue	O
3,	O
Pages	O
___	O
no	O
neurological	O
symptoms	O
followed	O
diagnosis	O
of	O
the	O
cancer,	O
rather	O
than	O
preceding	O
it	O
as	O
in	O
the	O
case	O
of	O
this	O
patient.	O
In	O
terms	O
of	O
the	O
P/Q-type	O
calcium	O
channel	O
antibody,	O
a	O
recent	O
review	O
of	O
236	O
___	O
patients	O
with	O
positive	O
voltage-gated	O
calcium	O
channel	O
antibodies	O
found	O
in	O
evaluation	O
for	O
paraneoplastic	O
neurological	O
autoimmunity,	O
there	O
was	O
only	O
one	O
patient	O
with	O
endometrial	O
adenocarcinoma	O
and	O
only	O
one	O
other	O
patient	O
with	O
adenocarcinoma	O
of	O
unknown	O
primary.	O
Patient	O
continued	O
to	O
improve	O
and	O
NIF	O
monitoring	O
was	O
discontinued	O
prior	O
to	O
discharge.	O
#	O
Cardiovascular:	O
A-fib:	O
s/p	O
ablation,	O
HTN	O
Sotalol	O
stopped	O
due	O
to	O
lower	O
BP's.	O
Subsequently	O
patient	O
became	O
hypertensive	O
SBP	O
150-180's	O
and	O
metoprolol	O
was	O
started	O
and	O
dose	O
increased	O
as	O
needed	O
to	O
25mg	O
BID.	O
Labetalol	O
___	O
mg	O
IV	O
Q6H	O
was	O
used	O
PRN	O
for	O
the	O
following	O
parameters:	O
for	O
SBP	O
>160	O
hold	O
for	O
HR	O
<60,	O
SBP	O
<90.	O
Patient	O
remained	O
persistently	O
hypertensive	O
and	O
amlodipine	O
5mg	O
was	O
added.	O
#	O
Positive	O
Urinalysis	O
on	O
admission:	O
UTI	O
vs	O
contamination	O
-Treated	O
with	O
ceftriaxone	O
(___)	O
given	O
clinical	O
scenario	O
and	O
concern	O
for	O
UTI	O
-URINE	O
CULTURE	O
___	O
(Final):	O
GRAM	O
POSITIVE	O
BACTERIA.	O
Alpha	O
hemolytic	O
colonies	O
consistent	O
with	O
alpha	O
streptococcus	O
or	O
Lactobacillus	O
sp.<	O
10,000	O
CFU/m	O
#Thrombocytopenia	O
and	O
VTE	O
prophylaxis:	O
Initially	O
started	O
on	O
Heparin	O
SC	O
BID.	O
However,	O
PLT	O
dropped	O
gradually	O
from	O
134	O
on	O
day	O
of	O
presentation	O
to	O
83	O
(~39%).	O
Concern	O
was	O
raised	O
regarding	O
Heparin	O
Induced	O
Thrombocytopenia,	O
since	O
patient	O
scored	O
4	O
on	O
the	O
4Ts	O
score	O
which	O
classified	O
her	O
as	O
intermediate	O
risk.	O
All	O
heparin	O
products	O
were	O
stopped	O
and	O
patient	O
was	O
switched	O
to	O
fondaparinux	O
SQ.	O
PF4	O
Heparin	O
Antibody	O
was	O
sent	O
on	O
___	O
and	O
returned	O
negative	O
for	O
HIT.	O
Patient	O
was	O
subsequently	O
restarted	O
on	O
SQ	O
heparin	O
for	O
DVT	O
prophylaxis.	O
#FEN/GI:	O
On	O
admission,	O
patient	O
endorsed	O
dysphagia	O
to	O
all	O
consistencies	O
of	O
food;	O
however,	O
most	O
prominently	O
to	O
solids.	O
Bedside	O
swallow	O
evaluation	O
was	O
conducted	O
by	O
Speech	O
Therapy	O
and	O
patient	O
was	O
deemed	O
unsafe	O
for	O
PO	O
feeds.	O
NG	O
tube	O
was	O
placed	O
on	O
___	O
and	O
she	O
was	O
started	O
on	O
continuous	O
feeds	O
with	O
Jevity	O
1.2,	O
goal	O
rate	O
to	O
meet	O
nutritional	O
needs	O
is	O
55ml/h.	O
On	O
___,	O
immediately	O
after	O
5	O
doses	O
of	O
IVIG,	O
there	O
was	O
a	O
video	O
swallow	O
study	O
which	O
revealed	O
aspiration	O
with	O
nectar	O
and	O
thin	O
consistencies.	O
Additionally	O
during	O
the	O
video	O
swallow	O
study,	O
there	O
was	O
a	O
concern	O
that	O
patient	O
was	O
not	O
activating	O
any	O
of	O
her	O
swallow	O
muscles.	O
NG	O
tube	O
feeds	O
were	O
continued.	O
Plan	O
to	O
repeat	O
video	O
prior	O
to	O
2	O
weeks	O
of	O
placement	O
of	O
NG	O
tube.	O
If	O
patient	O
does	O
not	O
show	O
improvement	O
in	O
swallowing,	O
she	O
may	O
require	O
G-tube	O
placement.	O
Glucose	O
was	O
monitored	O
closely	O
during	O
the	O
admission,	O
due	O
to	O
chronic	O
use	O
of	O
steroids.	O
Patient	O
was	O
started	O
sliding	O
scale	O
insulin.	O
There	O
was	O
no	O
bladder	B-Urinary_incontinence
or	O
bowel	B-Faecal_incontinence
incontinence,	B-Urinary_incontinence
except	O
for	O
1	O
episode	O
of	O
bowel	B-Faecal_incontinence
incontinence	B-Faecal_incontinence
when	O
patient's	O
stool	O
became	O
more	O
loose,	O
presumably	O
due	O
to	O
the	O
the	O
formula.	O
#HTN:	O
Home	O
sotalol	O
held	O
on	O
admission	O
but	O
started	O
metoprolol	O
to	O
25mg	O
BID	O
and	O
amlodipine	O
5mg	O
daily,	O
on	O
labetalol	O
PRN	O
for	O
SBP	O
>160.	O
Recent	O
pressures	O
140-150s/80s.	O
___	O
need	O
further	O
titration.	O
On	O
discharge***	O
#Dysphagia:	O
History	O
of	O
dysphagia	O
i/s/o	O
proximal	O
muscle	O
weakness	O
and	O
concern	O
for	O
bulbar	O
involvement.	O
Bedside	O
swallow	O
eval	O
deemed	O
patient	O
unsafe	O
for	O
PO	O
feeds,	O
NG	O
tube	O
placed	O
for	O
feeds.	O
Repeat	O
swallow	O
eval	O
prior	O
to	O
discharge	O
shows	O
improvement	O
but	O
ongoing	O
need	O
for	O
NG	O
tube.	O
Patient	O
discharged	O
with	O
NG	O
tube.	O
#GERD:	O
Continued	O
home	O
regimen	O
of	O
ranitidine.	O
#Social:	O
-	O
Health	O
Care	O
Proxy:	O
___,	O
husband	O
(___)	O
-	O
Husband	O
aware	O
of	O
undergoing	O
work-up	O
for	O
primary	O
cancer,	O
not	O
all	O
children	O
are	O
aware	O
yet,	O
patient	O
wishes	O
to	O
inform	O
them	O
at	O
a	O
later	O
time	O
TRANSITIONAL	O
ISSUES:	O
=====================	O
-	O
Please	O
follow	O
up	O
Myositis	O
antibody	O
panel	O
and	O
endometrial	O
biopsy	O
results	O
that	O
were	O
pending	O
at	O
the	O
time	O
of	O
discharge.	O
-	O
PICC	O
removed	O
prior	O
to	O
discharge,	O
ensure	O
patient	O
receives	O
a	O
port	O
prior	O
to	O
chemotherapy.	O
-	O
LFTs	O
slightly	O
elevated	O
prior	O
to	O
discharge.	O
Thought	O
to	O
be	O
chemotherapy	O
effect,	O
please	O
monitor.	O
-	O
Discharged	O
with	O
Dobhoff	O
and	O
tube	O
feeds.	O
If	O
patient	O
does	O
not	O
have	O
rapid	O
recovery	O
of	O
dysphasia,	O
can	O
consider	O
G-tube	O
placement.	O
Patient	O
will	O
have	O
home	O
speech/swallow	O
therapy.	O
Will	O
need	O
repeat	O
video	O
swallow	O
in	O
___	O
weeks.	O
-	O
Please	O
monitor	O
blood	O
glucose	O
and	O
downtitrate	O
insulin	O
regimen	O
as	O
steroids	O
are	O
tapered.	O
Discharged	O
on	O
Lantus	O
10mg	O
QHS.	O
-	O
Discharged	O
on	O
Atovaquone	O
for	O
PCP	O
prophylaxis	O
but	O
was	O
prohibitively	O
expensive	O
so	O
was	O
re-started	O
on	O
SS	O
TMP-SMX	O
given	O
prolonged	O
steroid	O
course.	O
Please	O
discontinue	O
after	O
steroids	O
are	O
stopped.	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Sotalol	O
30	O
mg	O
PO	O
BID	O
2.	O
Furosemide	O
20	O
mg	O
PO	O
DAILY:PRN	O
for	O
lower	O
extremity	O
edema	O
3.	O
Cyclobenzaprine	O
5	O
mg	O
PO	O
QHS	O
4.	O
Ranitidine	O
150	O
mg	O
PO	O
DAILY	O
Discharge	O
Medications:	O
1.	O
Acetaminophen	O
650	O
mg	O
PO	O
Q6H:PRN	O
Pain	O
-	O
Mild	O
2.	O
amLODIPine	O
5	O
mg	O
PO	O
DAILY	O
RX	O
*amlodipine	O
5	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
once	O
a	O
day	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
3.	O
Atovaquone	O
Suspension	O
1500	O
mg	O
PO	O
DAILY	O
PCP	O
ppx	O
RX	O
*atovaquone	O
750	O
mg/5	O
mL	O
10	O
ml	O
by	O
mouth	O
once	O
a	O
day	O
Disp	O
#*6300	O
Milliliter	O
Milliliter	O
Refills:*0	O
4.	O
Calcium	O
Carbonate	O
Suspension	O
1250	O
mg	O
PO	O
DAILY	O
Osteoporosis	O
prophylaxis	O
RX	O
*calcium	O
carbonate	O
500	O
mg/5	O
mL	O
calcium	O
(1,250	O
mg/5	O
mL)	O
12.5	O
ml	O
by	O
mouth	O
once	O
a	O
day	O
Disp	O
___	O
Milliliter	O
Milliliter	O
Refills:*0	O
5.	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
BID	O
6.	O
Furosemide	O
2	O
ml	O
PO/NG	O
DAILY	O
RX	O
*furosemide	O
10	O
mg/mL	O
2	O
ml	O
by	O
mouth	O
once	O
a	O
day	O
Refills:*0	O
7.	O
Glargine	O
10	O
Units	O
Bedtime	O
8.	O
Lansoprazole	O
Oral	O
Disintegrating	O
Tab	O
30	O
mg	O
PO	O
DAILY	O
RX	O
*lansoprazole	O
30	O
mg	O
1	O
capsule(s)	O
by	O
mouth	O
once	O
a	O
day	O
Disp	O
#*30	O
Capsule	O
Refills:*0	O
RX	O
*lansoprazole	O
[Prevacid	O
SoluTab]	O
30	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
once	O
a	O
day	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
9.	O
Metoclopramide	O
10	O
mg	O
PO	O
Q8H:PRN	O
nausea	O
RX	O
*metoclopramide	O
HCl	O
5	O
mg/5	O
mL	O
10	O
mL	O
by	O
mouth	O
Every	O
8	O
hours	O
as	O
needed	O
Disp	O
#*473	O
Milliliter	O
Milliliter	O
Refills:*0	O
10.	O
Metoprolol	O
Tartrate	O
25	O
mg	O
PO	O
BID	O
RX	O
*metoprolol	O
tartrate	O
25	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
twice	O
a	O
day	O
Disp	O
#*60	O
Tablet	O
Refills:*0	O
11.	O
Ondansetron	O
4	O
mg	O
PO	O
Q6H:PRN	O
nausea	O
RX	O
*ondansetron	O
4	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
every	O
six	O
(6)	O
hours	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
12.	O
Polyethylene	O
Glycol	O
17	O
g	O
PO	O
DAILY:PRN	O
constiption	B-Constipation
13.	O
PredniSONE	O
30	O
mg	O
PO	O
DAILY	O
RX	O
*prednisone	O
10	O
mg	O
3	O
tablet(s)	O
by	O
mouth	O
once	O
a	O
day	O
Disp	O
#*90	O
Tablet	O
Refills:*0	O
14.	O
Prochlorperazine	O
10	O
ml	O
PO	O
Q6H:PRN	O
nausea	O
RX	O
*prochlorperazine	O
maleate	O
10	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
every	O
six	O
(6)	O
hours	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
15.	O
Senna	O
8.6	O
mg	O
PO	O
BID:PRN	O
constipation	B-Constipation
16.	O
Vitamin	O
D	O
800	O
UNIT	O
PO	O
DAILY	O
Osteoporosis	O
prophylaxis	O
17.	O
HELD-	O
Cyclobenzaprine	O
5	O
mg	O
PO	O
QHS	O
This	O
medication	O
was	O
held.	O
Do	O
not	O
restart	O
Cyclobenzaprine	O
until	O
you	O
see	O
neuromuscular	O
doctor	O
18.Tubefeeds	O
Jevity	O
1.5	O
or	O
equivalent;	O
Full	O
strength	O
Goal	O
rate	O
60	O
mL/hr	O
Cycle:	O
6PM	O
to	O
12PM	O
Flush	O
w/	O
50mL	O
free	O
water	O
Q6h	O
Dispense	O
1	O
mnth	O
supply	O
with	O
2	O
refills	O
Discharge	O
Disposition:	O
Home	B-Lives_alone
With	O
Service	B-Has_carers
Facility:	O
___	O
Discharge	O
Diagnosis:	O
Primary:	O
Poorly	O
differentiated	O
Carcinoma	O
of	O
Mullerian	O
origin	O
(stage	O
IVb)	O
Secondary:	O
Paraneoplastic	O
syndrome,	O
Proximal	O
muscle	O
weakness,	O
Dysphagia,	O
Hypertension,	O
Dysphasia	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-GS
and	B-GS
coherent.	B-GS
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Mobile_with_assistance
-	B-Mobile_with_assistance
requires	B-Mobile_with_assistance
assistance	B-Mobile_with_assistance
or	O
aid	B-Mobile_with_aid
(walker	O
or	O
cane).	O
Discharge	O
Instructions:	O
Dear	O
Ms.	O
___,	O
Why	O
you	O
were	O
here?	O
You	O
were	O
admitted	O
because	O
you	O
had	O
weakness	O
and	O
shortness	O
of	O
breath.	O
What	O
we	O
did	O
while	O
you	O
were	O
here?	O
-You	O
were	O
found	O
to	O
have	O
a	O
paraneoplastic	O
syndrome.	O
We	O
monitored	O
your	O
breathing.	O
We	O
started	O
you	O
on	O
Prednisone	O
to	O
treat	O
this.	O
Your	O
weakness	O
improved.	O
-We	O
biopsied	O
your	O
lymph	O
node	O
and	O
found	O
that	O
you	O
had	O
Carcinoma.	O
The	O
Oncology	O
team	O
saw	O
you.	O
You	O
received	O
chemotherapy.	O
-Your	O
swallowing	O
muscles	O
were	O
weak.	O
We	O
gave	O
you	O
a	O
tube	O
to	O
help	O
with	O
your	O
feeding.	O
What	O
you	O
should	O
do	O
when	O
you	O
go	O
home?	B-Lives_alone
-	O
You	O
should	O
continue	O
to	O
take	O
all	O
of	O
your	O
new	O
medications.	O
-	O
You	O
should	O
continue	O
your	O
tube	O
feeding	O
with	O
the	O
help	O
of	O
your	O
visiting	O
nurse.	O
-	O
A	O
physical	O
therapist	O
and	O
speech	O
therapist	O
will	O
come	O
to	O
your	O
home	B-Lives_alone
to	O
work	O
with	O
you.	O
-	O
Call	O
your	O
doctor	O
if	O
you	O
develop	O
a	O
fever	O
greater	O
that	O
100.3,	O
persistent	O
vomiting,	O
persistent	O
diarrhea,	O
pain	O
that	O
does	O
not	O
resolve.	O
It	O
was	O
a	O
pleasure	O
taking	O
care	O
of	O
you!	O
Your	O
___	O
Team	O
Followup	O
Instructions:	O
___	O

